AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review

LE Targownik, DA Fisher, SD Saini - Gastroenterology, 2022 - Elsevier
Description Proton pump inhibitors (PPIs) are among the most commonly used medications
in the world. Developed for the treatment and prevention of acid-mediated upper …

The risks of long-term use of proton pump inhibitors: a critical review

M Jaynes, AB Kumar - Therapeutic advances in drug safety, 2019 - journals.sagepub.com
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their
use is likely even higher than estimated due to an increase in the number of PPIs available …

High-dimensional characterization of post-acute sequelae of COVID-19

Z Al-Aly, Y **e, B Bowe - Nature, 2021 - nature.com
The acute clinical manifestations of COVID-19 have been well characterized,, but the post-
acute sequelae of this disease have not been comprehensively described. Here we use the …

Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status

Y **e, B Bowe, Z Al-Aly - Nature communications, 2021 - nature.com
Abstract The Post-Acute Sequelae of SARS-CoV-2 infection (PASC) have been
characterized; however, the burden of PASC remains unknown. Here we used the …

[HTML][HTML] Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016

Y **e, B Bowe, AH Mokdad, H **an, Y Yan, T Li… - Kidney international, 2018 - Elsevier
The last quarter century witnessed significant population growth, aging, and major changes
in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) …

Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - Gastroenterology, 2019 - Elsevier
Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …

Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19

BT Garibaldi, K Wang, ML Robinson… - JAMA network …, 2021 - jamanetwork.com
Importance Clinical effectiveness data on remdesivir are urgently needed, especially among
diverse populations and in combination with other therapies. Objective To examine whether …

Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study

Y **e, B Bowe, G Maddukuri, Z Al-Aly - bmj, 2020 - bmj.com
Comparative evaluation of clinical manifestations and risk of death in patients admitted to
hospital with covid-19 and seasonal Page 1 the bmj | BMJ 2020;371:m4677 | doi: 10.1136/bmj.m4677 …

[HTML][HTML] Evidence-based nonpharmacologic strategies for comprehensive pain care: the consortium pain task force white paper

H Tick, A Nielsen, KR Pelletier, R Bonakdar… - Explore, 2018 - Elsevier
Medical pain management is in crisis; from the pervasiveness of pain to inadequate pain
treatment, from the escalation of prescription opioids to an epidemic in addiction, diversion …

Particulate matter air pollution and the risk of incident CKD and progression to ESRD

B Bowe, Y **e, T Li, Y Yan, H **an… - Journal of the American …, 2018 - journals.lww.com
Elevated levels of fine particulate matter< 2.5 µm in aerodynamic diameter (PM 2.5) are
associated with increased risk of cardiovascular outcomes and death, but their association …